Lv41
420 积分 2023-07-03 加入
A multicenter, randomized, double-blinded, placebo-controlled, dose-ranging study evaluating the efficacy and safety of vunakizumab in patients with moderate-to-severe plaque psoriasis
8天前
已完结
Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I study
14天前
已完结
Subcutaneously Administered Ofatumumab in Rheumatoid Arthritis: A Phase I/II Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics
14天前
已完结
Population Pharmacokinetic Modeling and Exposure–Efficacy and Body Weight–Response Analyses for Tezepelumab in Patients With Severe, Uncontrolled Asthma
15天前
已完结
Update on the Application of Monoclonal Antibody Therapy in Primary Membranous Nephropathy
1个月前
已完结
Mepolizumab in CRSwNP/ECRS and NP: the phase III randomised MERIT trial in Japan, China, and Russia
1个月前
已完结
[Expert consensus on the application of rituximab in the treatment of membranous nephropathy]
2个月前
已完结
A Systematic Review of Adaptive Seamless Clinical Trials for Late-Phase Oncology Development
2个月前
已完结
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
2个月前
已完结
Spectrum of biopsy-proven kidney diseases in northwest China: a review of 30 years of experiences
2个月前
已完结
皖公网安备34019202002308
